Superoxyde dismutase 1 gene abnormalities in familial amyotrophic lateral sclerosis: Phenotype/genotype correlations. The French experience and review of the literature;Les anomalies du gène superoxyde dismutase 1 dans la sclérose latérale amyotrophique familiale: Corrélations phénotype/génotype et implications pratiques. L'expérience française et revue de la littérature

Revue Neurologique

Volumn 160, Issue 1, 2004, Pages 44-50

  Jafari Schluep, H F ^a   Khoris, J ^a   Mayeux Portas, V ^a   Hand, C ^b   Rouleau, G ^b   Camu, W ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; DISEASE COURSE; DISEASE TRANSMISSION; FAMILIAL DISEASE; FRANCE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; ONSET AGE; REVIEW;

EID: 1542374575     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(04)70846-2     Document Type: Article

References (33)

1. AL-CHALABI A, ANDERSEN PM, CHIOZA B, et al. (1998). Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet, 7: 2045-2050.
2. ANDERSEN PM. (2001). Genetics of Sporadic ALS. Amyotroph Lateral Scler Other Motor Neuron Disord, 2: S37-S41.
3. ANDERSEN PM, FORSGREN L, BINZER M, et al. (1996). Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala Cu, Zn superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain, 119: 1153-1172.
4. AOKI M, OGASAWARA M, MATSUBARA Y, et al. (1993). Mild ALS in Japan associated with novel SOD mutation. Nat Genet, 5: 323-324.
5. ARAN FA. (1850). Recherches sur une maladie non encore décrite du système musculaire. Arch Gen Med, 24: 5-35.
6. BORCHELT DR, LEE MK, SLUNT HS, et al. (1994). Superoxide dismutase 1 with mutations linked to familial ALS possesses significant activity. Proc Natl Acad Sci, 91: 8292-8296.
7. BOUKAFTANE Y, KHORIS J, MOULARD B, et al. (1998). Identification of six novel SOD1 gene mutations in familial ALS patients. Can J Neurol Sci, 25: 192-196.
8. BROWN RH JR. (1995). ALS: recent insights from genetics and transgenic mice. Cell, 80: 687-692.
9. CALDER VL, DOMIGAN NM, GEORGE PM, DONALDSON IM, WINTER-BOURN CC. (1995). SOD glu100gly in a family with inherited motor neuron disease: detection of mutant SOD activity and the presence of heterodimers. Neurosci Lett, 189: 143-146.
10. CERONI M, MALASPINA A, POLONI TE, et al. (1999). Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation. Neurology, 53: 1064-1071.
11. CUDKOWICZ ME, McKENNA-YASEK D, CHEN C, HEDLEY-WHYTE ET, BROWN RH JR. (1998). Limited corticospinal Tract Involvement in ALS subjects with the A4V mutation in the Cu/Zn SOD1 gene. Ann Neurol, 43: 703-710.
12. CUDKOWICZ ME, McKENNA-YASEK D, SAPP PE, et al. (1997). Epidemiology of mutations in SOD in ALS. Ann Neurol, 41: 210-221.
13. DENG HX, HENTATI A, TAINER J, et al. (1993). ALS and structural defects in Cu, Zn SOD. Science, 261: 1047-1051.
14. ESTEBAN J, ROSEN DR, BOWLING AC, et al. (1994). Identification of two novel mutaions and a new polymorphism in the gene for Cu/Zn SOD in pateints with ALS. Hum Mol Genet, 3: 997-998.
15. GABBIANELLI R, FERRI A, ROTILIO G, CARRI MT. (1999). Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis. J Neurochem, 73: 1175-80.
16. GAUDETTE M, HIRANO M, SIDDIQUE T. (2000). Current status of SOD1 mutations in familial ALS. Amyotroph Lateral Scler Other Motor Neuron Disord, 1: 83-89.
17. GRONER Y, GIEMAN-HURWITZ J, DAFRI N, et al. (1986). The human Cu/Zn SOD gene family: architecture and expression of the chromosome 21-encoded functional gene and its processed pseudogenes. In: ROTILIS G, ed. Superoxide and superoxide dismutase in chemistry, biology and medicine. Amsterdam: Elsevier Science Publishers, Biochemical Division, pp 247-255.
18. HAND CK, MAYEUX-PORTAS V, KHORIS J, BRIOLOTTI V, CLAVELOU P, CAMU W, ROULEAU G. (2001). Compound heterozygous D90A and D96N SOD1 mutations in a recessive ALS family. Ann Neurol, 49: 267-271.
19. HAND CK, ROULEAU GA. (2002). Familial amyotrophic lateral sclerosis. Muscle Nerve, 25: 135-59.
20. HOTTINGER AF, FINE EG, GURNEY ME, ZURN AD, AEBISCHER P. (1997). The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci, 9: 1548-51.
21. JUNEJA T, PERICAK-VANCE MA, LAING NG, DAVE S, SIDDIQUE T. (1997). Prognosis in familial ALS. Neurology, 48: 55-57.
22. KURLAND LT, MULDER DW. (1954). Epidemiological investigations of ALS. Familial aggregations indicative of dominant inheritance. Part I & II. Neurology, 5: 182-267.
23. LI TM, ALBERMAN E, SWASH M. (1988). Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry, 51: 778-784.
24. MASĖ G, ROS S, GEMMA A, et al. (2001). ALS with variable phenotypes in a 6 generation family caused by Leu144Phe mutation in the SOD1 gene. J Neurol sci, 191: 11-8.
25. ROBBERECHT W, SAPP P, VIAENE MK, et al. (1994). Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem, 62: 384-7.
26. ROSEN DR, SIDDIQUE T, PATTERSON D, et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial ALS. Nature, 362: 59-62.
27. SHAW CE, ENAYAT ZE, CHIOZA BA, AL-CHALABI A, RADUNOVIC A, POWELL JF, LEIGH PN. (1998). Mutations in all five exons of SOD1 may cause ALS. Ann Neurol, 43: 390-394.
28. SHEFNER JM, REAM AG, FLOOO DG, et al. (1999). Mice lacking cytosolic Cu, Zn superoxide dismutase display a distinctive motor axonopathy. Neurology, 53: 1239-1246.
29. SIDDIQUE T, DENG HX. (1996). Genetics of ALS. Hum Mol Genet, 5: 1465-1470.
30. SIDDIQUE T, NIJHAWAN D, HENTATI A. (1996). Molecular genetic basis of familial ALS. Neurology, 47: S27-S35.
31. SJALANDER A, BECKMAN G, DENG HX, IQBAL Z, TAINER JA, SIDDIQUE T. (1995). The D90A mutation results in a polymorphism of Cu, Zn superoxide dismutase that is prevalent in northern Sweden and Finland. Hum Mol Genet, 4: 1105-1108.
32. WATANABE M, DYKES-HOBERG M, CULOTTA VC, PRICE DL, WONG PC, ROTHSTEIN JD. (2001). Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis, 8: 933-41.
33. YIM MB, KANG JH, YIM HS, KWAK HS, CHOCK PB, STADTMAN ER. (1996). A gain of function of an ALS associated Cu, Zn superoxide dismutase mutant: An enhancement of free radical formation due to decrease in Km for hydrogen peroxide. Proc Natl Acad Sci, 93: 5709-5714.